ViAqua is developing the first orally administered treatment for aquaculture to improve resistance to viral diseases and to prevent viral epidemics.
ViAqua’s platform for improving resistance to viral diseases in shellfish and fish utilizes a proprietary RNAi particle formulation that triggers a cell reaction to disable the viral infection. The coated particles are delivered via feed or immersion to produce maximum effect and to reduce costs.
Stage: Technology development
Founded: September 2014
Investor: The Trendlines Group
In the media: ViAqua founders interviewed about innovative research (nrg)
Achievement: Fish 2.0 competition finalist (2017)
Publication: Anti-viral RNAi nanoparticles protect shrimp against white spot disease (Royal Society of Chemistry)
Preventing and treating disease, particularly viral infections, is one of the major challenges facing aquaculture today. Currently, drugs to combat aquaculture diseases are generally injected into shellfish/fish one at a time. This labor-intensive and costly solution is relevant for large premium fish such as salmon, but it leaves shellfish and small fish unprotected, resulting in production losses of 20% or greater in certain species.
The underdeveloped area of virus/disease treatment in aquaculture is becoming a focus of interest and activity as the drive to increase food production for feeding the world’s growing population intensifies.
ViAqua’s first product is for shrimp, the most important aquaculture commodity, which accounts for 20% of the total international trade value of fish products. According to the USDA, diseases cause 10% to 20% losses in shrimp aquaculture. Delivery presents a major challenge for effective, economical treatment. Treatment for other shellfish (e.g., lobster, crab) and fish will follow.
ViAqua is now funding.
Send more information about ViAqua.
See the company one-page description in Chinese (PDF).
See the company presentation in Chinese (PDF).
ViAqua is the first orally administered treatment for aquaculture to improve resistance to viral diseases.
Autonomous system for detection and monitoring of crop diseases
Commercial production of materials from microalgae
Accuracy in fruit yield estimation
Bayer Trendlines Ag Innovation Fund
Robotic system for vegetable greenhouses
Increased mobility of agrochemical actives in plants
Enhancing fish growth